With subsequent LPS treatment (chosen due to its ability to produce robust immune responses, including exacerbations in IPF models [47]), both the never-frozen and frozen–thawed fibrotic hPCLS demonstrated similar fold enhancement of both TNF-α (Figure 3c) and IL-6 (Figure 3d). The gene discussed is IL6; the disease is idiopathic pulmonary fibrosis.